We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$82.8B
AUM Growth
+$1.44B
(+1.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
1,933
New
90
Increased
882
Reduced
857
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$366M |
| 2 |
CarMax
KMX
|
+$273M |
| 3 |
O'Reilly Automotive
ORLY
|
+$240M |
| 4 |
Motorola Solutions
MSI
|
+$212M |
| 5 |
Alibaba
BABA
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$401M |
| 2 |
TechnipFMC
FTI
|
+$399M |
| 3 |
AutoZone
AZO
|
+$327M |
| 4 |
Cisco
CSCO
|
+$232M |
| 5 |
NetEase
NTES
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Energy | 13.48% |
| 4 | Healthcare | 12.91% |
| 5 | Technology | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANSS
1801
DELISTED
Ansys
ANSS
| $212K | ﹤0.01% |
+1,438
| New | +$204K |
|
|
CLDT
1802
Chatham Lodging
CLDT
$630M
| $212K | ﹤0.01% |
9,327
-920
| -9% | -$20.6K |
|
1803
VeriSign
VRSN
$25.3B
| $210K | ﹤0.01% |
+1,833
| New | +$205K |
|
|
RPT
1804
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $208K | ﹤0.01% |
14,120
-155
| -1% | -$2.15K |
|
1805
Medifast
MED
$108M
| $207K | ﹤0.01% |
2,968
-746
| -20% | -$49.5K |
|
1806
Pathward Financial
CASH
$1.81B
| $206K | ﹤0.01% |
+6,675
| New | +$194K |
|
|
FSP
1807
Franklin Street Properties
FSP
$44.8M
| $203K | ﹤0.01% |
18,936
-1,155
| -6% | -$12.1K |
|
1808
PetMed Express
PETS
$42.5M
| $202K | ﹤0.01% |
+4,442
| New | +$175K |
|
|
MCRN
1809
DELISTED
Milacron Holdings Corp.
MCRN
| $201K | ﹤0.01% |
+10,490
| New | +$187K |
|
1810
QuinStreet
QNST
$870M
| $200K | ﹤0.01% |
23,896
-12,424
| -34% | -$106K |
|
1811
MiMedx Group
MDXG
$626M
| $199K | ﹤0.01% |
15,782
-185
| -1% | -$2.26K |
|
1812
Future Fuel
FF
$204M
| $197K | ﹤0.01% |
13,934
+1,295
| +10% | +$19.3K |
|
1813
WisdomTree
WT
$2.97B
| $184K | ﹤0.01% |
14,687
-3,559
| -20% | -$40.8K |
|
1814
Liquidity Services
LQDT
$1.17B
| $183K | ﹤0.01% |
37,599
+2,095
| +6% | +$11.4K |
|
|
PGRE
1815
DELISTED
Paramount Group
PGRE
| $182K | ﹤0.01% |
11,453
+373
| +3% | +$5.98K |
|
|
AQ
1816
DELISTED
Aquantia Corp. Common Stock
AQ
| $181K | ﹤0.01% |
+15,997
| New | +$181K |
|
1817
Bristow Group
VTOL
$1.35B
| $169K | ﹤0.01% |
7,838
-2
| -0% | -$42 |
|
1818
Innoviva
INVA
$1.58B
| $166K | ﹤0.01% |
11,693
+663
| +6% | +$8.84K |
|
1819
Babcock & Wilcox
BW
$1.43B
| $165K | ﹤0.01% |
+2,904
| New | +$132K |
|
|
BBG
1820
DELISTED
Bill Barrett Corp
BBG
| $165K | ﹤0.01% |
32,110
-8,697
| -21% | -$44.5K |
|
1821
LivePerson
LPSN
$18.9M
| $155K | ﹤0.01% |
899
+94
| +12% | +$17.6K |
|
|
CMO
1822
DELISTED
Capstead Mortgage Corp.
CMO
| $153K | ﹤0.01% |
17,616
+1,202
| +7% | +$11K |
|
|
TRST
1823
Trustco Bank Corp NY
TRST
$977M
| $146K | ﹤0.01% |
3,176
-398
| -11% | -$18.2K |
|
|
VIVO
1824
DELISTED
Meridian Bioscience Inc
VIVO
| $144K | ﹤0.01% |
10,278
+266
| +3% | +$3.89K |
|
1825
DHI Group
DHX
$166M
| $140K | ﹤0.01% |
73,290
+2,311
| +3% | +$4.79K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2017 Portfolio in Review
As of Q4 2017, OppenheimerFunds held 1,933 positions worth $82.8B, up 1.8% from $81.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
OppenheimerFunds's Q4 2017 filing shows 90 new, 882 increased, 857 reduced and 96 closed positions. Its largest new stake was Nebius Group N.V.: 5,110,710 shares worth $167M. The largest sale was Nektar Therapeutics, an estimated $401M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
- OppenheimerFunds's largest Q4 2017 buy was Nebius Group N.V.: 5,110,710 shares worth $167M.
- OppenheimerFunds added most to eBay in Q4 2017, an estimated $366M increase.
- OppenheimerFunds's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $401M.
- OppenheimerFunds fully exited NetEase in Q4 2017, selling an estimated $181M.
- OppenheimerFunds's ten largest holdings make up 16% of its $82.8B portfolio in Q4 2017.
- OppenheimerFunds opened 90 new positions and closed 96 in Q4 2017.
- OppenheimerFunds's portfolio value rose 1.8% quarter-over-quarter to $82.8B.
Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.